USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C

摘要

The present invention provides the use of PEG-IFN-alpha conjugates in association with Ribavirin for the manufacture of medicaments for the treatment of chronic hepatitis C infections. The present invention also provides a method for treating chronic hepatitis C infections in patients in need of such treating comprising administering an amount of PEG-IFN- alpha conjugate in association with an amount of Ribavirin effective to treat hepatitis C.